Sort
64,565 grants matching “drug discovery”
Discovery and Development of Organic Reactions Catalyzed by Transition Metals Valuable for Medicinal Chemistry
$687,888John F Hartwig · University Of California Berkeley · R35 · FY2019 · GM
Developing capsid-importin alpha inhibitors for the treatment of VEEV infection
$687,849Mikell Paige · George Mason University · R01 · FY2022 · AI
Optimization of Neoglycoside Antibiotics for Nosocomial Pathogens and Select Agen
$687,841George Louis Drusano · University Of Florida · R01 · FY2012 · AI
Bloomington Drosophila Stock Center at Indiana University
$687,840Kevin R Cook · Trustees Of Indiana University · P40 · FY2016 · OD
Bloomington Drosophila Stock Center at Indiana University
$687,840Kevin R Cook · Trustees Of Indiana University · P40 · FY2014 · OD
Biosynthesis of Amino Acid Derived Quinone Cofactors
$687,824Caroline Mary Wilmot · University Of Minnesota · R01 · FY2009 · GM
Project 2: Use of 2D cultures and 3D organoids to identify candidate antiviral compounds; to use genetic approaches to identify host genes that promote or protect against flavivirus infection
$687,797Lee Gehrke · Massachusetts Institute Of Technology · U19 · FY2017 · AI
Protein Tyrosine Dephosphorylation & Signal Transduction
$687,770Nicholas K Tonks · Cold Spring Harbor Laboratory · R01 · FY2011 · CA
Novel method to create knockout rats using endonucleases and spermatogonial stem
$687,732Tseten Yeshi Jamling · Hera Testing Laboratories, Inc. · R44 · FY2014 · GM
Kinases as Therapeutic Targets for Endometriosis
$687,714Martin M Matzuk · Baylor College Of Medicine · R01 · FY2023 · HD
Kinases as Therapeutic Targets for Endometriosis
$687,714Martin M Matzuk · Baylor College Of Medicine · R01 · FY2025 · HD
Kinases as Therapeutic Targets for Endometriosis
$687,714Martin M Matzuk · Baylor College Of Medicine · R01 · FY2022 · HD
Rational optimization of combinatorial therapies for the treatment of rare cystic fibrosis variants
$687,705Jonathan Patrick Schlebach · Purdue University · R01 · FY2023 · HL
Engineered Stem Cells for Cardiac Repair
$687,578Michael Regnier · University Of Washington · R01 · FY2019 · HL
Synthetic mRNA-mediated reversible immunocontraception
$687,538Philip J Santangelo · Emory University · R33 · FY2021 · HD
A DRUG DISCOVERY PIPELINE FOR FIGHTING BREAST CANCER METASTASIS
$687,488Regents Of The University Of California, San Francisco, The · · FY2020 · Department of the Army
Developmental Funds Core
$687,479Andrew K Godwin · University Of Kansas Medical Center · P30 · FY2022 · CA
Functional consequences of cancer mutations
$687,395Chris Sander · Sloan-Kettering Inst Can Research · R01 · FY2012 · CA
A Scalable Neuron-Based High-Throughput Screening Platform for the Discovery of Compounds that Restore Protein Expression Caused by Genetic Haploinsufficiency
$687,348Gavin R Rumbaugh · Scripps Florida · R01 · FY2017 · MH
Investigate the role of extracellular vesicles in promoting the progression of pulmonary lymphangioleiomyomatosis
$687,328Magdalena Karbowniczek · Texas Tech University Health Scis Center · R01 · FY2025 · HL
Identifying Prognostic Markers and Therapeutic Targets for Serous Ovarian Cancer
$687,307Susan J Ramus · University Of Southern California · R01 · FY2015 · CA
Career Development and Training Program
$687,296David H Walker · University Of Texas Med Br Galveston · U54 · FY2010 · AI
Chromatin regions, genes and pathways that confer susceptibility to chemical-induced DNA damage
$687,113Ivan Rusyn · Texas A&M Agrilife Research · R01 · FY2019 · ES
Genomic Architecture of Functional Brain Networks in PTSD
$687,090Rajendra A Morey · Duke University · R01 · FY2023 · MH
Extending the utility and performance of variant effect predictors with protein language models
$687,063Vasileios Ntranos · University Of California, San Francisco · R01 · FY2025 · HG